Sigma slashed on earnings downgrade

Sigma-PharmaShares in pharmacies supplier Sigma Healthcare have plunged after the company warned that underlying earnings will come in below market expectations, citing “challenging” industry conditions.

Sigma expects full-year earnings for the 2018 fiscal year of around $90 million, compared to current market consensus of around $95 million.

In an announcement to the ASX on Friday, the company also said it now expected first-half earnings to come in around $44 million.

Shares in Sigma were down 8.1 per cent to 85.5 cents at 1301 AEST.

Sigma said it had taken steps to lift its sales performance and grow its market share, to overcome “general market conditions”.

Chief executive Mark Hooper said the business was confident of improvement.

“Sigma delivered above guidance growth in FY17 and remains confident that our business strategy and increased investment in infrastructure will deliver growth and efficiency improvements beyond the current year,” he said in the statement.

The company is due to announce its results on September 7.

Access exclusive analysis, locked news and reports with Inside Retail Weekly. Subscribe today and get our premium print publication delivered to your door every week.


Comment Manually

Inside Retail Polls

Schwarz Group, Aldi and the big two
How will the Aussie entry of either Kaufland or Lidl impact the supermarket industry?

Inside Retail Directory


Why do shopping centres struggle with innovation so much?

2 days ago

US president says Amazon causing “great damage" to tax-paying retailers.

2 days ago

You don't need much AI to work out that different climates means different jackets.

2 days ago

FREE NEWS BRIEFS Get breaking news delivered